Company / Operating Income per Share
Vertex Pharmaceuticals Operating Income per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
$16.24
FY2025
5-year range
-$0.90 / $16.93
FY2021-FY2025
Trend
+1897.1%
vs FY2024
Sector context
#5 of 201
Health Care
What the data says
Operating Income per Share changed +1897% YoY in FY2025, a notable deviation from the 9-year average annual change of +399%.
Based on SEC 10-K filings.
16.24 in FY2025 with a 5-year CAGR of +8.1%. Top quartile in the Health Care sector.
Improved from $14.91 to $16.24 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -1.4%
- 5-Year CAGR
- +8.1%
- 10-Year CAGR
- -
Sector benchmark
Top 2% in Health CareTop 2% of 201This company $16.24 Sector average -$28.56
▼
+156.9% above sector average
Key checks
Key Insights
- In FY2025, operating income per share increased 1897.1% year-over-year.
- Ranks #5 out of 201 companies in the Health Care sector.
- Peak operating income per share was recorded in FY2022.
- Lowest operating income per share in the period was in FY2024.
Company context
Key Data Points
- Strong profit margin: 31.4%
- Strong return on equity: 21.2%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $16.24 | +1897.1% |
| FY2024 | -$0.90 | -106.1% |
| FY2023 | $14.91 | -11.9% |
| FY2022 | $16.93 | +58.1% |
| FY2021 | $10.70 | -2.9% |
| FY2020 | $11.03 | +135.0% |
| FY2019 | $4.69 | +87.1% |
| FY2018 | $2.51 | +405.3% |
| FY2017 | $0.50 | +1130.4% |
| FY2016 | $0.04 | +102.1% |
As of FY2025 · SEC 10-K · Updated Mar 17, 2026